Skip to main content
. 2015 Apr 25;25(11):1407–1417. doi: 10.1002/hipo.22460

Figure 3.

Figure 3

KAR or mGluR antagonists applied alone do not affect MF-LTP. (A, B) The GluK1 antagonists ACET (A: 0.1 nmol, i.h.; n = 5) or UBP161 (B, 1 nmol, i.h.; n = 5) fail to block MF-LTP. (C–F) The broad spectrum mGluR antagonist MCPG (C, 5 nmol, i.h.; n = 5), the mGlu5 receptor antagonist, MPEP (D, 1 nmol, i.h.; n = 4), the mGlu1 receptor antagonist LY367385 (E, 1 nmol, i.h.; n = 4) or the combination of LY367385 and MPEP (F, 1 and 1 nmol, i.h.; n = 4) does not block MF-LTP.